abstract |
The present invention relates to compounds of formula (I) wherein R1, R2, and X are as defined in the description and claims, and pharmaceutically acceptable salts thereof. The compounds are useful for the treatment and / or prevention of diseases that are associated with DPP IV, such as diabetes, particularly non-insulin dependent diabetes mellitus, and decreased glucose tolerance. |